©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Increase of Solubility of Foreign Proteins in Escherichia coli by Coproduction of the Bacterial Thioredoxin (*)

(Received for publication, July 12, 1995; and in revised form, September 1, 1995)

Takashi Yasukawa (1) (2) Chie Kanei-Ishii (1) Toshio Maekawa (1) Jiro Fujimoto (3) Tadashi Yamamoto (3) Shunsuke Ishii (1) (2)(§)

From the  (1)Laboratory of Molecular Genetics, The Institute of Physical and Chemical Research (RIKEN), 3-1-1 Koyadai, Tsukuba, Ibaraki 305, Japan, the (2)Institute of Medical Sciences, University of Tsukuba, 1-1-1 Tennoudai, Tsukuba, Ibaraki 305, Japan, and the (3)Department of Oncology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Eukaryotic proteins are frequently produced in Escherichia coli as insoluble aggregates. This is one of the barriers to studies of macromolecular structure. We have examined the effect of coproduction of the E. coli thioredoxin (Trx) or E. coli chaperones GroESL on the solubility of various foreign proteins. The solubilities of all eight vertebrate proteins examined including transcription factors and kinases were increased dramatically by coproduction of Trx. Overproduction of E. coli chaperones GroESL increased the solubilities of four out of eight proteins examined. Although the tyrosine kinase Lck that was produced as an insoluble form and solubilized by urea treatment had a very low autophosphorylating activity, Lck produced in soluble form by coproduction of Trx had an efficient activity. These results suggest that the proteins produced in soluble form by coproduction of Trx have the native protein conformation. The mechanism by which coproduction of Trx increases the solubility of the foreign proteins is discussed.


INTRODUCTION

Production of large amounts of proteins in Escherichia coli is a first step for structural studies of macromolecules. However, many eukaryotic proteins, especially full-length proteins, are produced in E. coli as insoluble aggregates (inclusion bodies). Our laboratory is interested in the three-dimensional structure of transcription factors, especially nuclear oncogene products such as the myb proto-oncogene product (c-Myb). We identified the solution structure of the Myb-DNA complex by using the bacterially produced Myb protein containing the DNA-binding domain alone(1) . However, the structural study of the full-length Myb has been unsuccessful, because it was produced in E. coli as insoluble aggregates. Although production of a protein as insoluble aggregates can offer the advantage of easy purification, a protein solubilized by some appropriate process such as urea treatment does not have a guarantee that it has the native protein conformation. Thus, large-scale production of eukaryotic proteins in E. coli in soluble form is the first step for structural studies.

The mechanism by which proteins become soluble is not understood. The formation of inclusion bodies might be thought as ``inappropriate'' protein-protein interactions due to the lack of proper polypeptide folding(2, 3) . Why are many eukaryotic proteins produced as insoluble aggregates in E. coli? Two factors appear to affect the solubility of eukaryotic proteins in E. coli. The first parameter is the E. coli heat shock chaperone GroESL (encoded by the groE operon, Fig. 1). The role of the GroESL complex in catalyzing the correct folding of a newly synthesized polypeptide has become firmly established recently(4, 5, 6, 7) . To produce eukaryotic proteins in E. coli, a strong promoter like the T7 promoter is often used. In this case, a high level of production of the E. coli chaperones GroESL may be needed. For example, when phage infects E. coli, the production of GroESL is induced. If the level of functional GroESL does not increase, phage cannot form the phage particles, because the folding of coat proteins does not occur correctly(8) . Thus, the coordinate induction and high level production of E. coli chaperones may be required for proper folding of the foreign proteins. The second parameter that affects the solubility of eukaryotic proteins in E. coli could be the difference of redox state between E. coli and eukaryotic cells. Most of the fusion proteins with GST (^1)(glutathione S-transferase) containing various mammalian proteins produced in E. coli bind to glutathione-Sepharose beads very efficiently. In contrast, the GST-fusion proteins produced in mammalian cells bind to glutathione beads only with low efficiency. (^2)This observation suggests that mammalian cells have a different redox environment from E. coli. Consistent with this observation, it was reported that quite high concentrations of glutathione are maintained in mammalian cells(9) .


Figure 1: Expression vector for E. coli chaperones GroESL or E. coli Trx. A, structure of the GroESL or Trx expression vector. The GroESL- or Trx-coding region was linked to the T7 promoter and inserted into pACYC vector containing the chloramphenicol resistance marker. B, induction of GroESL or Trx production. E. coli BL21(DE3) harboring GroESL or Trx expression vector was cultivated to A of 0.7 (IPTG(-)), or was then cultivated for 4 h more in the presence of 1 mM IPTG (IPTG(+)). Total lysates were prepared and centrifuged to separate the soluble and insoluble fractions. Samples prepared from 0.4 and 0.7 ml of culture were analyzed by 10% (for GroEL) (left) and 15% (for GroES and Trx) (right) SDS-PAGE followed by Coomassie staining.



We report here that the solubility of various eukaryotic proteins in E. coli is increased by coproducing E. coli thioredoxin (Trx). By coproducing Trx, eight foreign proteins including transcription factors and oncogene products were successfully produced in soluble form. The effect of Trx coproduction on the solubility of foreign proteins is compared with that of GroE coproduction.


MATERIALS AND METHODS

Construction of Plasmids

To make the pACYC plasmid containing the T7 promoter (pACYC-T7), the HindIII-SphI 0.5-kb DNA fragment of pACYC184 (10) was replaced by the 0.6-kb HindIII-SphI fragment containing the T7 promoter from the pAR2156 vector(11, 12) . The NdeI-BglII 2.1-kb DNA fragment containing the GroESL-coding region was made by the polymerase chain reaction using the groE plasmid (pKV1561) (13) and inserted into the NdeI-BamHI site of pACYC-T7 to generate the plasmid to produce E. coli GroESL under the control of T7 promoter (pT-GroE). To make the plasmid in which the T7 promoter was linked to the E. coli Trx-coding region (pT-Trx)(14) , the NdeI-HindIII fragment of pT-GroE was replaced by the NdeI-HindIII fragment containing the Trx-coding region and the aspA transcription terminator. The plasmids to produce various vertebrate proteins were constructed using the appropriate pET expression vector containing the T7 promoter (11, 12) and cDNA clones.

Bacterial Strains and Production of Proteins

The E. coli strain BL21(DE3) (11, 12) harboring pT-GroE, pT-Trx, or pET vector to produce various vertebrate proteins was made by transformation with each plasmid. To generate the bacteria to produce both foreign protein and GroE or Trx, the E. coli strain BL21(DE3) harboring pT-GroE or pT-Trx was transformed by pET vector encoding various vertebrate proteins. The bacteria was cultivated in 2.5 ml of superbroth to A of 0.7, and then production of the proteins was induced with 1 mM isopropyl-1-thio-beta-D-galactopyranoside (IPTG) for 4 h. Bacteria were pelleted, washed with phosphate-buffered saline (130 mM NaCl, 2.7 mM KCl, 10 mM potassium phosphate buffer, pH 7.2), suspended in 150 µl of buffer A (50 mM Tris-HCl, pH 7.5, 5 mM MgCl(2), 0.5 mM EDTA, 0.1 M NaCl), and disrupted by sonication. After centrifugation, the supernatant was rescued as the soluble fraction. The pellet was suspended into 200 µl of SDS sample buffer, boiled for 3 min, and centrifuged. The supernatant was rescued as the insoluble fraction.

Autophosphorylation Assay of the Human lck Gene Product (Lck)

E. coli BL21(DE3) harboring a pET vector to produce Lck with or without Trx expression vector was cultivated, and production of Lck was induced by IPTG for 3 h. The bacterial pellet was suspended into 1/25 volume of buffer L (50 mM Tris-HCl, pH 8.0, 0.5 mM EDTA, 50 mM NaCl, 1 mM dithiothreitol, 0.125 mM phenylmethylsulfonyl fluoride) containing four protease inhibitors (soybean trypsin inhibitor, antipain, pepstatin A, chymostatin, and leupeptin; each 10 µg/ml), and disrupted by sonication. After centrifugation, the supernatant containing the soluble form of Lck was rescued and stored (soluble Lck). The insoluble pellet containing the insoluble form of Lck was suspended into 1/50 volume of buffer L containing 8 M urea, stood on ice for 1 h, and centrifuged. The supernatant was rescued, dialyzed against buffer L, and stored (urea-treated insoluble sample). Autophosphorylating activity of Lck was examined by using the Lck-specific antibody as described(15) .


RESULTS

We tried to examine the effect of coproduction of E. coli Trx or E. coli chaperones GroESL on the solubility of vertebrate proteins in E. coli. The pET vector, which contains the T7 promoter and a pBR322-based replicon(11, 12) , was used to produce foreign proteins. To coproduce GroESL or Trx with a level similar to that of foreign proteins of interest, the GroESL- or Trx-coding region was also linked to the T7 promoter and inserted into the pACYC vector, which contains a p15A replicon and a chloramphenicol resistance marker (10) (Fig. 1A). The generated plasmids, pT-GroE or pT-Trx, allowed for cotransformation with the pET plasmids to produce various vertebrate proteins based upon plasmid compatibility. To confirm the production of GroESL or Trx from these plasmids, the BL21(DE3) bacteria transformed with pT-GroE or pT-Trx plasmids was cultivated in the presence or absence of IPTG. Fig. 1B shows the Coomassie staining of the total proteins of each culture following SDS-PAGE. The overproduction of GroEL and GroES from pT-GroE or Trx from pT-Trx is striking, with over 30% of the total cellular protein being GroESL or Trx.

We first examined the effects of coproduction of GroESL on the solubility of various vertebrate proteins (Fig. 2, see lanes marked by +GroE). To produce various foreign proteins, the BL21(DE3) transformants harboring the pET plasmid alone or both the pET plasmid and pT-GroE were made. To assess the production and solubility of each of the proteins, cultures were harvested 4 h postinduction, the cell pellets were lysed by sonication, and the resulting lysates were separated into soluble and insoluble fractions by centrifugation. The proteins in both fractions were separated by SDS-PAGE followed by Coomassie staining. Without coproduction of GroESL, mouse c-Myb (16) was produced completely as insoluble aggregates. However, coproduction of GroESL significantly increased the solubility of Myb, and approximately 10% of c-Myb was produced in soluble form, resulting in the production level of about 20 mg of soluble form per liter of culture. Similar increases in solubility were observed with two other human transcription factors, cAMP response element-binding protein 1 (CRE-BP1) (also called ATF-2) (17) and the p53 tumor suppressor gene product(18) . However, coproduction of GroESL did not increase the solubility of three other nuclear factors, the ski-related gene product SnoN(19) , myc proto-oncogene product (Myc)(20) , and adenovirus oncogene product E1A (21) . We have also examined the effects of coproduction of GroESL on the solubility of vertebrate kinases. The solubility of one of the Ser/Thr kinases, the Xenopus mos proto-oncogene product (Mos)(22) , increased significantly, but the solubility of one of the tyrosine kinases, Lck(23, 24) , which is a member of the src gene family, did not. Thus, coproduction of GroESL improved the solubility of four foreign proteins out of the eight examined.


Figure 2: Increase of solubility of mammalian proteins by coproduction of GroESL or Trx. E. coli BL21(DE3) harboring the pET expression vector to produce various proteins indicated on the right with (+) or without(-) GroESL expression vector (GroE) or Trx expression vector (Trx) was cultivated to A of 0.7 (IPTG(-)), and was then cultivated for 4 h more in the presence (IPTG(+)) or absence (IPTG(-)) of 1 mM IPTG. The soluble (marked by S) and insoluble (marked by I) fractions were prepared and analyzed on 10% or 8% SDS-PAGE followed by Coomassie staining.



We then examined the effects of coproduction of Trx on the solubility of eight proteins described above (Fig. 2, see lanes marked by +Trx). The solubility of c-Myb was dramatically increased by coproduction of Trx, and about 30 mg of the soluble form of c-Myb were produced per liter of culture. Similarly, coproduction of Trx improved the solubility of CRE-BP1, p53, Mos, and Lck, and approximately 30-100 mg of soluble forms were produced per liter of culture. Although all of Myc and SnoN were produced as insoluble aggregates even in the presence of GroESL, significant amounts of Myc and SnoN were produced in soluble form by coproduction of Trx. About half of E1A was produced in soluble form in the absence of Trx, while most of E1A was soluble in the presence of Trx, resulting in production of about 70 mg of the soluble form of E1A per liter of culture. Thus, Trx increased the solubility of all eight foreign proteins examined, indicating that the Trx coproduction system is more useful than the GroE system.

Does foreign protein produced in soluble form by coproduction of Trx have the native conformation? To examine this, we have analyzed the autophosphorylating activity of Lck (Fig. 3). Lck was produced in soluble form by using the Trx coproduction system (Fig. 3, lanes 1-4). On the other hand, Lck produced as insoluble form without coproduction of Trx was solubilized by urea treatment (Fig. 3, lanes 5-8). Two forms of Lck were immunoprecipitated by the Lck-specific antibody and incubated with [-P]ATP to measure the autophosphorylating activity. The specific activity of soluble Lck was 10 times higher than that of urea-treated insoluble materials. These results indicate that only a small portion of molecules have the native conformation in the protein sample solubilized by urea. In contrast, the proteins produced in soluble form by coproduction of Trx appear to have the native protein conformation.


Figure 3: Autophosphorylation of Lck produced in E. coli. Various amounts of Lck produced in soluble form and the urea-treated Lck produced in insoluble form were immunoprecipitated with the Lck-specific antibody. To confirm that similar amounts of Lck were precipitated between two preparations, samples of the precipitates were analyzed by SDS-PAGE followed by Western blotting by the Lck-specific antibody (upper). The remaining precipitates were incubated with [-P]ATP to measure the autophosphorylating activity and then analyzed by SDS-PAGE followed by autoradiography (lower).




DISCUSSION

We have demonstrated that coproduction of Trx dramatically increases the solubility of all eight foreign proteins examined in E. coli. However, an increase of the solubility by coproduction of GroESL was observed with only four of the eight proteins examined. These results indicate that the Trx coproduction system is more useful than the GroE system to produce foreign proteins as soluble forms. By making the plasmid to coproduce both Trx and GroE, we have also examined whether overproduction of both Trx and GroE can more effectively increase the solubility of vertebrate proteins than that of either protein. However, we have observed no additional effects of overproduction of either Trx or GroE.^2 Improvement of the solubility of foreign proteins by overproduction of GroESL was reported recently by other groups with human procollagenase (25) or human Csk(26) . In spite of the obvious effect on the solubility of procollagenase, Lee and Olins (25) reported that overproduction of GroESL had no effect on the solubility of three other proteins. Our better results with GroE (four successful cases out of eight) than in the other report could be due to the high level of production of GroESL under the control of the T7 promoter.

It was reported that the use of Trx as a gene fusion partner increases the solubility of foreign proteins like cytokines(27) . However, our finding that the overproduction of free Trx dramatically increases the solubility of foreign proteins is clearly different from this. This finding give us a big advantage in preparing the large amount of proteins for structural study. In the case of fusion proteins, Trx has to be cleaved off by a specific peptidase, but the efficiency of cleavage is often very low. Increase of the solubility of foreign proteins by overproduction of Trx strongly suggests that the redox state affects the solubility of foreign proteins. Our observation that many GST-fusion proteins produced in mammalian cells bound to glutathione-Sepharose beads much less efficiently than those produced in E. coli cells suggest that E. coli cells have the relatively oxidative environment compared to mammalian cells. This could induce formation of abnormal intramolecular disulfide bonds that aggregate the proteins. Another observation that addition of a reducing reagent in the process of solubilization of insoluble aggregates of c-Myb by urea or guanidine hydrochloride increases the efficiency of obtaining the functional proteins^2 may support this speculation.

Comparison of the activity of Lck between the soluble form and the solubilized form by urea indicates that the soluble form has higher activity than the urea-treated form, indicating that only a portion of the molecules in the urea-treated sample has a native protein conformation. These results show that the artificially solubilized protein sample is not suitable for structural study. Recently, we have succeeded in purifying the large amount of full-length c-Myb protein produced as a soluble form using the Trx system. This c-Myb protein sample will be useful not only for crystal study but also for various experiments to examine the interaction between c-Myb and other proteins. The Trx coproduction system allows us to prepare many mammalian proteins suitable for structural study and molecular biological study.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed. Tel.: 81-298-36-9031; Fax: 81-298-36-9030; sishii@rtcs1.rtc.riken.go.jp.

(^1)
The abbreviations used are: GST, glutathione S-transferase; CRE-BP1, cAMP response element-binding protein 1; E1A, adenovirus E1A gene product; GroESL, groES and groEL gene products; Trx, E. coli thioredoxin; kb, kilobase(s); IPTG, isopropyl-1-thio-beta-D-galactopyranoside; PAGE, polyacrylamide gel electrophoresis.

(^2)
T. Yasukawa, C. Kanei-Ishii, T. Maekawa, J. Fujimoto, T. Yamamoto, and S. Ishii, unpublished data.


ACKNOWLEDGEMENTS

We thank T. Yura for the groE plasmid, K. Okazaki and N. Sagata for the Mos expression plasmid, and Y. Koga for the Lck-specific antibody.


REFERENCES

  1. Ogata, K., Morikawa, S., Nakamura, H., Sekikawa, A., Inoue, T., Kanai, H., Sarai, A., Ishii, S., and Nishimura, Y. (1994) Cell 79, 639-648 [Medline] [Order article via Infotrieve]
  2. Schein, C. H. (1989) Bio/Technology 7, 1141-1149
  3. Mitraki, A., and King, J. (1989) Bio/Technology 7, 690-697
  4. Weissman, J. S., Kashi, Y., Fenton, W. A., and Horwich, A. L. (1994) Cell 78, 693-702 [Medline] [Order article via Infotrieve]
  5. Schmidt, M., Rutkat, K., Rachel, R., Pfeifer, G., Jaenicke, R., Viitanen, P. V., Lorimer, G. H., and Buchner, J. (1994) Science 265, 656-659 [Medline] [Order article via Infotrieve]
  6. Azem, A., Kessel, M., and Goloubinoff, P. (1994) Science 265, 653-656 [Medline] [Order article via Infotrieve]
  7. Martin, J., Mayhew, M., Langer, T., and Hartl, F. U. (1993) Nature 366, 228-233 [CrossRef][Medline] [Order article via Infotrieve]
  8. Georgopoulos, C., Ang, D., Liberek, K., and Zylicz, M. (1990) in Stress Proteins in Biology and Medicine (Morimoto, R. I., Tissieres, A., and Georgopoulos, C., eds) pp. 191-221, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  9. Kondo, T., Yoshida, K., Urata, Y., Goto, S., Gasa, S., and Taniguchi, N. (1993) J. Biol. Chem. 268, 20366-20372 [Abstract/Free Full Text]
  10. Chang, A. C. Y., and Cohen, S. N. (1978) J. Bacteriol. 134, 1141-1156 [Medline] [Order article via Infotrieve]
  11. Studier F. W., and Moffatt, B. A. (1986) J. Mol. Biol. 189, 113-130 [Medline] [Order article via Infotrieve]
  12. Rosenberg, A. H., Lade, B. N., Chui, D.-S., Lin, S.-W., Dunn, J. J., and Studier, F. W. (1987) Gene (Amst.) 56, 125-135 [CrossRef][Medline] [Order article via Infotrieve]
  13. Kanemori, M., Mori, H., and Yura, T. (1994) J. Bacteriol. 176, 4235-4242 [Abstract]
  14. Lunn, C. A., Kathju, S., Wallace, B. J., Kushner, S. R., and Pigiet, V. (1984) J. Biol. Chem. 259, 10469-10474 [Abstract/Free Full Text]
  15. Yamanashi, Y., Kakiuchi, T., Mizuguchi, J., Yamamoto, T., and Toyoshima, K. (1991) Science 251, 192-194 [Medline] [Order article via Infotrieve]
  16. Sakura, H., Kanei-Ishii, C., Nagase, T., Nakagoshi, H., Gonda, T. J., and Ishii, S. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 5758-5762 [Abstract]
  17. Maekawa, T., Sakura, H., Kanei-Ishii, C., Sudo, T., Yoshimura, T., Fujisawa, J., Yoshida, M., and Ishii, S. (1989) EMBO J. 8, 2023-2028 [Abstract]
  18. Vogelstein, B., and Kinzler, K. W. (1992) Cell 70, 523-526 [Medline] [Order article via Infotrieve]
  19. Nagase, T., Nomura, N., and Ishii, S. (1993) J. Biol Chem. 268, 13710-13716 [Abstract/Free Full Text]
  20. Lüscher, B., and Eisenman, R. N. (1990) Genes & Dev. 4, 2025-2035
  21. Moran, E., and Mathews, M. B. (1987) Cell 48, 177-178 [Medline] [Order article via Infotrieve]
  22. Sagata, N., Watanabe, N., Vande Woude, G. F., and Ikawa, Y. (1989) Nature 342, 512-518 [CrossRef][Medline] [Order article via Infotrieve]
  23. Marth, J. D., Peet, R., Krebs, E. G., and Perlmutter, R. M. (1985) Cell 43, 393-404 [Medline] [Order article via Infotrieve]
  24. Voronova, A. F., and Sefton, B. M. (1986) Nature 319, 682-685 [Medline] [Order article via Infotrieve]
  25. Lee, S. C., and Olins, P. O. (1992) J. Biol. Chem. 267, 2849-2852 [Abstract/Free Full Text]
  26. Amrein, K. E., Tacaks, B., Stieger, M., Molnos, J., Flint, N. A., and Burn, P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 1048-1052 [Abstract]
  27. LaVallie, E. R., DiBlasio, E. A., Kovacic, S., Grant, K. L., Schendel, P. F., and McCoy, J. M. (1993) Bio/Technology 11, 187-193 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.